Stock info Usana Health Sciences Inc | Filter  Basic-Info

Usana Health Sciences Inc

The past year gave good returns for Usana Health Sciences Inc investors

Over the past year the company' stock lost around 53 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 107 percent. Usana Health Sciences Inc's revenues between 2011 and 2015 were very volatile through the time and moved between 648,73 million dollars and 918,5 million dollars. During 2011 and 2015 Usana Health Sciences Inc's net results were very volatile and fluctuated between 24,03 million dollars and 94,67 million dollars.

Usana Health Sciences Inc primarily operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The American company didn't pay out any dividends (in the past 5 years).

Healthy financed: not so much debt Usana Health Sciences Inc

At the end of 2015 the American company had a balance sheet of around 423,24 million dollars. 142,39 million dollars (33,64 percent of the total balance sheet) was financed by debt. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio 14. So the stock' value was 14 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 1,58 billion dollars. At the end of 2015 the American company had around 12,73 million stocks listed on the exchanges.

All the company's financial reports are available here. More information about Usana Health Sciences Inc can be found it's website. .